Global Amantadine HCl Oral Market Growth 2025-2031

October 2025 | 144 pages | ID: G53C6383E17EN
LP Information

Abstracts

The global Amantadine HCl Oral market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.

The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.

Amantadine is a medication that has U.S. Food and Drug Administration approval for use both as an antiviral and an antiparkinsonian medication.

United States market for Amantadine HCl Oral is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Amantadine HCl Oral is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Amantadine HCl Oral is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Amantadine HCl Oral players cover Zydus Pharmaceuticals, Mylan, Teva, Vertical Pharmaceuticals, Adamas Pharmaceuticals, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LP Information, Inc. (LPI) ' newest research report, the ?Amantadine HCl Oral Industry Forecast? looks at past sales and reviews total world Amantadine HCl Oral sales in 2024, providing a comprehensive analysis by region and market sector of projected Amantadine HCl Oral sales for 2025 through 2031. With Amantadine HCl Oral sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Amantadine HCl Oral industry.

This Insight Report provides a comprehensive analysis of the global Amantadine HCl Oral landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Amantadine HCl Oral portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Amantadine HCl Oral market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Amantadine HCl Oral and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Amantadine HCl Oral.

This report presents a comprehensive overview, market shares, and growth opportunities of Amantadine HCl Oral market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:

• Tablet
• Capsules
• Syrup

Segmentation by Application:

• Parkinson's Disease
• Influenza

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.

• Zydus Pharmaceuticals
• Mylan
• Teva
• Vertical Pharmaceuticals
• Adamas Pharmaceuticals
• Upsher-Smith
• Sandoz
• Mikart Pharmaceuticals
• Pharmaceutical Associates, Inc. (PAI)
• Wockhardt Bio AG
• CMP Pharma
• Bionpharma
• Graviti Pharma
• Alembic Pharmaceuticals
• Strides Pharma
• Heritage Pharmaceuticals

Key Questions Addressed in this Report

What is the 10-year outlook for the global Amantadine HCl Oral market?
What factors are driving Amantadine HCl Oral market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Amantadine HCl Oral market opportunities vary by end market size?
How does Amantadine HCl Oral break out by Type, by Application?

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Amantadine HCl Oral Annual Sales 2020-2031
  2.1.2 World Current & Future Analysis for Amantadine HCl Oral by Geographic Region, 2020, 2024 & 2031
  2.1.3 World Current & Future Analysis for Amantadine HCl Oral by Country/Region, 2020, 2024 & 2031
2.2 Amantadine HCl Oral Segment by Type
  2.2.1 Tablet
  2.2.2 Capsules
  2.2.3 Syrup
2.3 Amantadine HCl Oral Sales by Type
  2.3.1 Global Amantadine HCl Oral Sales Market Share by Type (2020-2025)
  2.3.2 Global Amantadine HCl Oral Revenue and Market Share by Type (2020-2025)
  2.3.3 Global Amantadine HCl Oral Sale Price by Type (2020-2025)
2.4 Amantadine HCl Oral Segment by Application
  2.4.1 Parkinson's Disease
  2.4.2 Influenza
2.5 Amantadine HCl Oral Sales by Application
  2.5.1 Global Amantadine HCl Oral Sale Market Share by Application (2020-2025)
  2.5.2 Global Amantadine HCl Oral Revenue and Market Share by Application (2020-2025)
  2.5.3 Global Amantadine HCl Oral Sale Price by Application (2020-2025)

3 GLOBAL BY COMPANY

3.1 Global Amantadine HCl Oral Breakdown Data by Company
  3.1.1 Global Amantadine HCl Oral Annual Sales by Company (2020-2025)
  3.1.2 Global Amantadine HCl Oral Sales Market Share by Company (2020-2025)
3.2 Global Amantadine HCl Oral Annual Revenue by Company (2020-2025)
  3.2.1 Global Amantadine HCl Oral Revenue by Company (2020-2025)
  3.2.2 Global Amantadine HCl Oral Revenue Market Share by Company (2020-2025)
3.3 Global Amantadine HCl Oral Sale Price by Company
3.4 Key Manufacturers Amantadine HCl Oral Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Amantadine HCl Oral Product Location Distribution
  3.4.2 Players Amantadine HCl Oral Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy

4 WORLD HISTORIC REVIEW FOR AMANTADINE HCL ORAL BY GEOGRAPHIC REGION

4.1 World Historic Amantadine HCl Oral Market Size by Geographic Region (2020-2025)
  4.1.1 Global Amantadine HCl Oral Annual Sales by Geographic Region (2020-2025)
  4.1.2 Global Amantadine HCl Oral Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Amantadine HCl Oral Market Size by Country/Region (2020-2025)
  4.2.1 Global Amantadine HCl Oral Annual Sales by Country/Region (2020-2025)
  4.2.2 Global Amantadine HCl Oral Annual Revenue by Country/Region (2020-2025)
4.3 Americas Amantadine HCl Oral Sales Growth
4.4 APAC Amantadine HCl Oral Sales Growth
4.5 Europe Amantadine HCl Oral Sales Growth
4.6 Middle East & Africa Amantadine HCl Oral Sales Growth

5 AMERICAS

5.1 Americas Amantadine HCl Oral Sales by Country
  5.1.1 Americas Amantadine HCl Oral Sales by Country (2020-2025)
  5.1.2 Americas Amantadine HCl Oral Revenue by Country (2020-2025)
5.2 Americas Amantadine HCl Oral Sales by Type (2020-2025)
5.3 Americas Amantadine HCl Oral Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Amantadine HCl Oral Sales by Region
  6.1.1 APAC Amantadine HCl Oral Sales by Region (2020-2025)
  6.1.2 APAC Amantadine HCl Oral Revenue by Region (2020-2025)
6.2 APAC Amantadine HCl Oral Sales by Type (2020-2025)
6.3 APAC Amantadine HCl Oral Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Amantadine HCl Oral by Country
  7.1.1 Europe Amantadine HCl Oral Sales by Country (2020-2025)
  7.1.2 Europe Amantadine HCl Oral Revenue by Country (2020-2025)
7.2 Europe Amantadine HCl Oral Sales by Type (2020-2025)
7.3 Europe Amantadine HCl Oral Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Amantadine HCl Oral by Country
  8.1.1 Middle East & Africa Amantadine HCl Oral Sales by Country (2020-2025)
  8.1.2 Middle East & Africa Amantadine HCl Oral Revenue by Country (2020-2025)
8.2 Middle East & Africa Amantadine HCl Oral Sales by Type (2020-2025)
8.3 Middle East & Africa Amantadine HCl Oral Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Amantadine HCl Oral
10.3 Manufacturing Process Analysis of Amantadine HCl Oral
10.4 Industry Chain Structure of Amantadine HCl Oral

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Amantadine HCl Oral Distributors
11.3 Amantadine HCl Oral Customer

12 WORLD FORECAST REVIEW FOR AMANTADINE HCL ORAL BY GEOGRAPHIC REGION

12.1 Global Amantadine HCl Oral Market Size Forecast by Region
  12.1.1 Global Amantadine HCl Oral Forecast by Region (2026-2031)
  12.1.2 Global Amantadine HCl Oral Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Amantadine HCl Oral Forecast by Type (2026-2031)
12.7 Global Amantadine HCl Oral Forecast by Application (2026-2031)

13 KEY PLAYERS ANALYSIS

13.1 Zydus Pharmaceuticals
  13.1.1 Zydus Pharmaceuticals Company Information
  13.1.2 Zydus Pharmaceuticals Amantadine HCl Oral Product Portfolios and Specifications
  13.1.3 Zydus Pharmaceuticals Amantadine HCl Oral Sales, Revenue, Price and Gross Margin (2020-2025)
  13.1.4 Zydus Pharmaceuticals Main Business Overview
  13.1.5 Zydus Pharmaceuticals Latest Developments
13.2 Mylan
  13.2.1 Mylan Company Information
  13.2.2 Mylan Amantadine HCl Oral Product Portfolios and Specifications
  13.2.3 Mylan Amantadine HCl Oral Sales, Revenue, Price and Gross Margin (2020-2025)
  13.2.4 Mylan Main Business Overview
  13.2.5 Mylan Latest Developments
13.3 Teva
  13.3.1 Teva Company Information
  13.3.2 Teva Amantadine HCl Oral Product Portfolios and Specifications
  13.3.3 Teva Amantadine HCl Oral Sales, Revenue, Price and Gross Margin (2020-2025)
  13.3.4 Teva Main Business Overview
  13.3.5 Teva Latest Developments
13.4 Vertical Pharmaceuticals
  13.4.1 Vertical Pharmaceuticals Company Information
  13.4.2 Vertical Pharmaceuticals Amantadine HCl Oral Product Portfolios and Specifications
  13.4.3 Vertical Pharmaceuticals Amantadine HCl Oral Sales, Revenue, Price and Gross Margin (2020-2025)
  13.4.4 Vertical Pharmaceuticals Main Business Overview
  13.4.5 Vertical Pharmaceuticals Latest Developments
13.5 Adamas Pharmaceuticals
  13.5.1 Adamas Pharmaceuticals Company Information
  13.5.2 Adamas Pharmaceuticals Amantadine HCl Oral Product Portfolios and Specifications
  13.5.3 Adamas Pharmaceuticals Amantadine HCl Oral Sales, Revenue, Price and Gross Margin (2020-2025)
  13.5.4 Adamas Pharmaceuticals Main Business Overview
  13.5.5 Adamas Pharmaceuticals Latest Developments
13.6 Upsher-Smith
  13.6.1 Upsher-Smith Company Information
  13.6.2 Upsher-Smith Amantadine HCl Oral Product Portfolios and Specifications
  13.6.3 Upsher-Smith Amantadine HCl Oral Sales, Revenue, Price and Gross Margin (2020-2025)
  13.6.4 Upsher-Smith Main Business Overview
  13.6.5 Upsher-Smith Latest Developments
13.7 Sandoz
  13.7.1 Sandoz Company Information
  13.7.2 Sandoz Amantadine HCl Oral Product Portfolios and Specifications
  13.7.3 Sandoz Amantadine HCl Oral Sales, Revenue, Price and Gross Margin (2020-2025)
  13.7.4 Sandoz Main Business Overview
  13.7.5 Sandoz Latest Developments
13.8 Mikart Pharmaceuticals
  13.8.1 Mikart Pharmaceuticals Company Information
  13.8.2 Mikart Pharmaceuticals Amantadine HCl Oral Product Portfolios and Specifications
  13.8.3 Mikart Pharmaceuticals Amantadine HCl Oral Sales, Revenue, Price and Gross Margin (2020-2025)
  13.8.4 Mikart Pharmaceuticals Main Business Overview
  13.8.5 Mikart Pharmaceuticals Latest Developments
13.9 Pharmaceutical Associates, Inc. (PAI)
  13.9.1 Pharmaceutical Associates, Inc. (PAI) Company Information
  13.9.2 Pharmaceutical Associates, Inc. (PAI) Amantadine HCl Oral Product Portfolios and Specifications
  13.9.3 Pharmaceutical Associates, Inc. (PAI) Amantadine HCl Oral Sales, Revenue, Price and Gross Margin (2020-2025)
  13.9.4 Pharmaceutical Associates, Inc. (PAI) Main Business Overview
  13.9.5 Pharmaceutical Associates, Inc. (PAI) Latest Developments
13.10 Wockhardt Bio AG
  13.10.1 Wockhardt Bio AG Company Information
  13.10.2 Wockhardt Bio AG Amantadine HCl Oral Product Portfolios and Specifications
  13.10.3 Wockhardt Bio AG Amantadine HCl Oral Sales, Revenue, Price and Gross Margin (2020-2025)
  13.10.4 Wockhardt Bio AG Main Business Overview
  13.10.5 Wockhardt Bio AG Latest Developments
13.11 CMP Pharma
  13.11.1 CMP Pharma Company Information
  13.11.2 CMP Pharma Amantadine HCl Oral Product Portfolios and Specifications
  13.11.3 CMP Pharma Amantadine HCl Oral Sales, Revenue, Price and Gross Margin (2020-2025)
  13.11.4 CMP Pharma Main Business Overview
  13.11.5 CMP Pharma Latest Developments
13.12 Bionpharma
  13.12.1 Bionpharma Company Information
  13.12.2 Bionpharma Amantadine HCl Oral Product Portfolios and Specifications
  13.12.3 Bionpharma Amantadine HCl Oral Sales, Revenue, Price and Gross Margin (2020-2025)
  13.12.4 Bionpharma Main Business Overview
  13.12.5 Bionpharma Latest Developments
13.13 Graviti Pharma
  13.13.1 Graviti Pharma Company Information
  13.13.2 Graviti Pharma Amantadine HCl Oral Product Portfolios and Specifications
  13.13.3 Graviti Pharma Amantadine HCl Oral Sales, Revenue, Price and Gross Margin (2020-2025)
  13.13.4 Graviti Pharma Main Business Overview
  13.13.5 Graviti Pharma Latest Developments
13.14 Alembic Pharmaceuticals
  13.14.1 Alembic Pharmaceuticals Company Information
  13.14.2 Alembic Pharmaceuticals Amantadine HCl Oral Product Portfolios and Specifications
  13.14.3 Alembic Pharmaceuticals Amantadine HCl Oral Sales, Revenue, Price and Gross Margin (2020-2025)
  13.14.4 Alembic Pharmaceuticals Main Business Overview
  13.14.5 Alembic Pharmaceuticals Latest Developments
13.15 Strides Pharma
  13.15.1 Strides Pharma Company Information
  13.15.2 Strides Pharma Amantadine HCl Oral Product Portfolios and Specifications
  13.15.3 Strides Pharma Amantadine HCl Oral Sales, Revenue, Price and Gross Margin (2020-2025)
  13.15.4 Strides Pharma Main Business Overview
  13.15.5 Strides Pharma Latest Developments
13.16 Heritage Pharmaceuticals
  13.16.1 Heritage Pharmaceuticals Company Information
  13.16.2 Heritage Pharmaceuticals Amantadine HCl Oral Product Portfolios and Specifications
  13.16.3 Heritage Pharmaceuticals Amantadine HCl Oral Sales, Revenue, Price and Gross Margin (2020-2025)
  13.16.4 Heritage Pharmaceuticals Main Business Overview
  13.16.5 Heritage Pharmaceuticals Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Amantadine HCl Oral Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Amantadine HCl Oral Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players ofTablet
Table 4. Major Players of Capsules
Table 5. Major Players of Syrup
Table 6. Global Amantadine HCl Oral Sales by Type (2020-2025) & (K Units)
Table 7. Global Amantadine HCl Oral Sales Market Share by Type (2020-2025)
Table 8. Global Amantadine HCl Oral Revenue by Type (2020-2025) & ($ million)
Table 9. Global Amantadine HCl Oral Revenue Market Share by Type (2020-2025)
Table 10. Global Amantadine HCl Oral Sale Price by Type (2020-2025) & (USD/Unit)
Table 11. Global Amantadine HCl Oral Sale by Application (2020-2025) & (K Units)
Table 12. Global Amantadine HCl Oral Sale Market Share by Application (2020-2025)
Table 13. Global Amantadine HCl Oral Revenue by Application (2020-2025) & ($ million)
Table 14. Global Amantadine HCl Oral Revenue Market Share by Application (2020-2025)
Table 15. Global Amantadine HCl Oral Sale Price by Application (2020-2025) & (USD/Unit)
Table 16. Global Amantadine HCl Oral Sales by Company (2020-2025) & (K Units)
Table 17. Global Amantadine HCl Oral Sales Market Share by Company (2020-2025)
Table 18. Global Amantadine HCl Oral Revenue by Company (2020-2025) & ($ millions)
Table 19. Global Amantadine HCl Oral Revenue Market Share by Company (2020-2025)
Table 20. Global Amantadine HCl Oral Sale Price by Company (2020-2025) & (USD/Unit)
Table 21. Key Manufacturers Amantadine HCl Oral Producing Area Distribution and Sales Area
Table 22. Players Amantadine HCl Oral Products Offered
Table 23. Amantadine HCl Oral Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 24. New Products and Potential Entrants
Table 25. Market M&A Activity & Strategy
Table 26. Global Amantadine HCl Oral Sales by Geographic Region (2020-2025) & (K Units)
Table 27. Global Amantadine HCl Oral Sales Market Share Geographic Region (2020-2025)
Table 28. Global Amantadine HCl Oral Revenue by Geographic Region (2020-2025) & ($ millions)
Table 29. Global Amantadine HCl Oral Revenue Market Share by Geographic Region (2020-2025)
Table 30. Global Amantadine HCl Oral Sales by Country/Region (2020-2025) & (K Units)
Table 31. Global Amantadine HCl Oral Sales Market Share by Country/Region (2020-2025)
Table 32. Global Amantadine HCl Oral Revenue by Country/Region (2020-2025) & ($ millions)
Table 33. Global Amantadine HCl Oral Revenue Market Share by Country/Region (2020-2025)
Table 34. Americas Amantadine HCl Oral Sales by Country (2020-2025) & (K Units)
Table 35. Americas Amantadine HCl Oral Sales Market Share by Country (2020-2025)
Table 36. Americas Amantadine HCl Oral Revenue by Country (2020-2025) & ($ millions)
Table 37. Americas Amantadine HCl Oral Sales by Type (2020-2025) & (K Units)
Table 38. Americas Amantadine HCl Oral Sales by Application (2020-2025) & (K Units)
Table 39. APAC Amantadine HCl Oral Sales by Region (2020-2025) & (K Units)
Table 40. APAC Amantadine HCl Oral Sales Market Share by Region (2020-2025)
Table 41. APAC Amantadine HCl Oral Revenue by Region (2020-2025) & ($ millions)
Table 42. APAC Amantadine HCl Oral Sales by Type (2020-2025) & (K Units)
Table 43. APAC Amantadine HCl Oral Sales by Application (2020-2025) & (K Units)
Table 44. Europe Amantadine HCl Oral Sales by Country (2020-2025) & (K Units)
Table 45. Europe Amantadine HCl Oral Revenue by Country (2020-2025) & ($ millions)
Table 46. Europe Amantadine HCl Oral Sales by Type (2020-2025) & (K Units)
Table 47. Europe Amantadine HCl Oral Sales by Application (2020-2025) & (K Units)
Table 48. Middle East & Africa Amantadine HCl Oral Sales by Country (2020-2025) & (K Units)
Table 49. Middle East & Africa Amantadine HCl Oral Revenue Market Share by Country (2020-2025)
Table 50. Middle East & Africa Amantadine HCl Oral Sales by Type (2020-2025) & (K Units)
Table 51. Middle East & Africa Amantadine HCl Oral Sales by Application (2020-2025) & (K Units)
Table 52. Key Market Drivers & Growth Opportunities of Amantadine HCl Oral
Table 53. Key Market Challenges & Risks of Amantadine HCl Oral
Table 54. Key Industry Trends of Amantadine HCl Oral
Table 55. Amantadine HCl Oral Raw Material
Table 56. Key Suppliers of Raw Materials
Table 57. Amantadine HCl Oral Distributors List
Table 58. Amantadine HCl Oral Customer List
Table 59. Global Amantadine HCl Oral Sales Forecast by Region (2026-2031) & (K Units)
Table 60. Global Amantadine HCl Oral Revenue Forecast by Region (2026-2031) & ($ millions)
Table 61. Americas Amantadine HCl Oral Sales Forecast by Country (2026-2031) & (K Units)
Table 62. Americas Amantadine HCl Oral Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 63. APAC Amantadine HCl Oral Sales Forecast by Region (2026-2031) & (K Units)
Table 64. APAC Amantadine HCl Oral Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 65. Europe Amantadine HCl Oral Sales Forecast by Country (2026-2031) & (K Units)
Table 66. Europe Amantadine HCl Oral Revenue Forecast by Country (2026-2031) & ($ millions)
Table 67. Middle East & Africa Amantadine HCl Oral Sales Forecast by Country (2026-2031) & (K Units)
Table 68. Middle East & Africa Amantadine HCl Oral Revenue Forecast by Country (2026-2031) & ($ millions)
Table 69. Global Amantadine HCl Oral Sales Forecast by Type (2026-2031) & (K Units)
Table 70. Global Amantadine HCl Oral Revenue Forecast by Type (2026-2031) & ($ millions)
Table 71. Global Amantadine HCl Oral Sales Forecast by Application (2026-2031) & (K Units)
Table 72. Global Amantadine HCl Oral Revenue Forecast by Application (2026-2031) & ($ millions)
Table 73. Zydus Pharmaceuticals Basic Information, Amantadine HCl Oral Manufacturing Base, Sales Area and Its Competitors
Table 74. Zydus Pharmaceuticals Amantadine HCl Oral Product Portfolios and Specifications
Table 75. Zydus Pharmaceuticals Amantadine HCl Oral Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 76. Zydus Pharmaceuticals Main Business
Table 77. Zydus Pharmaceuticals Latest Developments
Table 78. Mylan Basic Information, Amantadine HCl Oral Manufacturing Base, Sales Area and Its Competitors
Table 79. Mylan Amantadine HCl Oral Product Portfolios and Specifications
Table 80. Mylan Amantadine HCl Oral Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 81. Mylan Main Business
Table 82. Mylan Latest Developments
Table 83. Teva Basic Information, Amantadine HCl Oral Manufacturing Base, Sales Area and Its Competitors
Table 84. Teva Amantadine HCl Oral Product Portfolios and Specifications
Table 85. Teva Amantadine HCl Oral Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 86. Teva Main Business
Table 87. Teva Latest Developments
Table 88. Vertical Pharmaceuticals Basic Information, Amantadine HCl Oral Manufacturing Base, Sales Area and Its Competitors
Table 89. Vertical Pharmaceuticals Amantadine HCl Oral Product Portfolios and Specifications
Table 90. Vertical Pharmaceuticals Amantadine HCl Oral Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 91. Vertical Pharmaceuticals Main Business
Table 92. Vertical Pharmaceuticals Latest Developments
Table 93. Adamas Pharmaceuticals Basic Information, Amantadine HCl Oral Manufacturing Base, Sales Area and Its Competitors
Table 94. Adamas Pharmaceuticals Amantadine HCl Oral Product Portfolios and Specifications
Table 95. Adamas Pharmaceuticals Amantadine HCl Oral Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 96. Adamas Pharmaceuticals Main Business
Table 97. Adamas Pharmaceuticals Latest Developments
Table 98. Upsher-Smith Basic Information, Amantadine HCl Oral Manufacturing Base, Sales Area and Its Competitors
Table 99. Upsher-Smith Amantadine HCl Oral Product Portfolios and Specifications
Table 100. Upsher-Smith Amantadine HCl Oral Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 101. Upsher-Smith Main Business
Table 102. Upsher-Smith Latest Developments
Table 103. Sandoz Basic Information, Amantadine HCl Oral Manufacturing Base, Sales Area and Its Competitors
Table 104. Sandoz Amantadine HCl Oral Product Portfolios and Specifications
Table 105. Sandoz Amantadine HCl Oral Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 106. Sandoz Main Business
Table 107. Sandoz Latest Developments
Table 108. Mikart Pharmaceuticals Basic Information, Amantadine HCl Oral Manufacturing Base, Sales Area and Its Competitors
Table 109. Mikart Pharmaceuticals Amantadine HCl Oral Product Portfolios and Specifications
Table 110. Mikart Pharmaceuticals Amantadine HCl Oral Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 111. Mikart Pharmaceuticals Main Business
Table 112. Mikart Pharmaceuticals Latest Developments
Table 113. Pharmaceutical Associates, Inc. (PAI) Basic Information, Amantadine HCl Oral Manufacturing Base, Sales Area and Its Competitors
Table 114. Pharmaceutical Associates, Inc. (PAI) Amantadine HCl Oral Product Portfolios and Specifications
Table 115. Pharmaceutical Associates, Inc. (PAI) Amantadine HCl Oral Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 116. Pharmaceutical Associates, Inc. (PAI) Main Business
Table 117. Pharmaceutical Associates, Inc. (PAI) Latest Developments
Table 118. Wockhardt Bio AG Basic Information, Amantadine HCl Oral Manufacturing Base, Sales Area and Its Competitors
Table 119. Wockhardt Bio AG Amantadine HCl Oral Product Portfolios and Specifications
Table 120. Wockhardt Bio AG Amantadine HCl Oral Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 121. Wockhardt Bio AG Main Business
Table 122. Wockhardt Bio AG Latest Developments
Table 123. CMP Pharma Basic Information, Amantadine HCl Oral Manufacturing Base, Sales Area and Its Competitors
Table 124. CMP Pharma Amantadine HCl Oral Product Portfolios and Specifications
Table 125. CMP Pharma Amantadine HCl Oral Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 126. CMP Pharma Main Business
Table 127. CMP Pharma Latest Developments
Table 128. Bionpharma Basic Information, Amantadine HCl Oral Manufacturing Base, Sales Area and Its Competitors
Table 129. Bionpharma Amantadine HCl Oral Product Portfolios and Specifications
Table 130. Bionpharma Amantadine HCl Oral Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 131. Bionpharma Main Business
Table 132. Bionpharma Latest Developments
Table 133. Graviti Pharma Basic Information, Amantadine HCl Oral Manufacturing Base, Sales Area and Its Competitors
Table 134. Graviti Pharma Amantadine HCl Oral Product Portfolios and Specifications
Table 135. Graviti Pharma Amantadine HCl Oral Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 136. Graviti Pharma Main Business
Table 137. Graviti Pharma Latest Developments
Table 138. Alembic Pharmaceuticals Basic Information, Amantadine HCl Oral Manufacturing Base, Sales Area and Its Competitors
Table 139. Alembic Pharmaceuticals Amantadine HCl Oral Product Portfolios and Specifications
Table 140. Alembic Pharmaceuticals Amantadine HCl Oral Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 141. Alembic Pharmaceuticals Main Business
Table 142. Alembic Pharmaceuticals Latest Developments
Table 143. Strides Pharma Basic Information, Amantadine HCl Oral Manufacturing Base, Sales Area and Its Competitors
Table 144. Strides Pharma Amantadine HCl Oral Product Portfolios and Specifications
Table 145. Strides Pharma Amantadine HCl Oral Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 146. Strides Pharma Main Business
Table 147. Strides Pharma Latest Developments
Table 148. Heritage Pharmaceuticals Basic Information, Amantadine HCl Oral Manufacturing Base, Sales Area and Its Competitors
Table 149. Heritage Pharmaceuticals Amantadine HCl Oral Product Portfolios and Specifications
Table 150. Heritage Pharmaceuticals Amantadine HCl Oral Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 151. Heritage Pharmaceuticals Main Business
Table 152. Heritage Pharmaceuticals Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Picture of Amantadine HCl Oral
Figure 2. Amantadine HCl Oral Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Amantadine HCl Oral Sales Growth Rate 2020-2031 (K Units)
Figure 7. Global Amantadine HCl Oral Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Amantadine HCl Oral Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Amantadine HCl Oral Sales Market Share by Country/Region (2024)
Figure 10. Amantadine HCl Oral Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture ofTablet
Figure 12. Product Picture of Capsules
Figure 13. Product Picture of Syrup
Figure 14. Global Amantadine HCl Oral Sales Market Share by Type in 2025
Figure 15. Global Amantadine HCl Oral Revenue Market Share by Type (2020-2025)
Figure 16. Amantadine HCl Oral Consumed in Parkinson's Disease
Figure 17. Global Amantadine HCl Oral Market: Parkinson's Disease (2020-2025) & (K Units)
Figure 18. Amantadine HCl Oral Consumed in Influenza
Figure 19. Global Amantadine HCl Oral Market: Influenza (2020-2025) & (K Units)
Figure 20. Global Amantadine HCl Oral Sale Market Share by Application (2024)
Figure 21. Global Amantadine HCl Oral Revenue Market Share by Application in 2025
Figure 22. Amantadine HCl Oral Sales by Company in 2025 (K Units)
Figure 23. Global Amantadine HCl Oral Sales Market Share by Company in 2025
Figure 24. Amantadine HCl Oral Revenue by Company in 2025 ($ millions)
Figure 25. Global Amantadine HCl Oral Revenue Market Share by Company in 2025
Figure 26. Global Amantadine HCl Oral Sales Market Share by Geographic Region (2020-2025)
Figure 27. Global Amantadine HCl Oral Revenue Market Share by Geographic Region in 2025
Figure 28. Americas Amantadine HCl Oral Sales 2020-2025 (K Units)
Figure 29. Americas Amantadine HCl Oral Revenue 2020-2025 ($ millions)
Figure 30. APAC Amantadine HCl Oral Sales 2020-2025 (K Units)
Figure 31. APAC Amantadine HCl Oral Revenue 2020-2025 ($ millions)
Figure 32. Europe Amantadine HCl Oral Sales 2020-2025 (K Units)
Figure 33. Europe Amantadine HCl Oral Revenue 2020-2025 ($ millions)
Figure 34. Middle East & Africa Amantadine HCl Oral Sales 2020-2025 (K Units)
Figure 35. Middle East & Africa Amantadine HCl Oral Revenue 2020-2025 ($ millions)
Figure 36. Americas Amantadine HCl Oral Sales Market Share by Country in 2025
Figure 37. Americas Amantadine HCl Oral Revenue Market Share by Country (2020-2025)
Figure 38. Americas Amantadine HCl Oral Sales Market Share by Type (2020-2025)
Figure 39. Americas Amantadine HCl Oral Sales Market Share by Application (2020-2025)
Figure 40. United States Amantadine HCl Oral Revenue Growth 2020-2025 ($ millions)
Figure 41. Canada Amantadine HCl Oral Revenue Growth 2020-2025 ($ millions)
Figure 42. Mexico Amantadine HCl Oral Revenue Growth 2020-2025 ($ millions)
Figure 43. Brazil Amantadine HCl Oral Revenue Growth 2020-2025 ($ millions)
Figure 44. APAC Amantadine HCl Oral Sales Market Share by Region in 2025
Figure 45. APAC Amantadine HCl Oral Revenue Market Share by Region (2020-2025)
Figure 46. APAC Amantadine HCl Oral Sales Market Share by Type (2020-2025)
Figure 47. APAC Amantadine HCl Oral Sales Market Share by Application (2020-2025)
Figure 48. China Amantadine HCl Oral Revenue Growth 2020-2025 ($ millions)
Figure 49. Japan Amantadine HCl Oral Revenue Growth 2020-2025 ($ millions)
Figure 50. South Korea Amantadine HCl Oral Revenue Growth 2020-2025 ($ millions)
Figure 51. Southeast Asia Amantadine HCl Oral Revenue Growth 2020-2025 ($ millions)
Figure 52. India Amantadine HCl Oral Revenue Growth 2020-2025 ($ millions)
Figure 53. Australia Amantadine HCl Oral Revenue Growth 2020-2025 ($ millions)
Figure 54. China Taiwan Amantadine HCl Oral Revenue Growth 2020-2025 ($ millions)
Figure 55. Europe Amantadine HCl Oral Sales Market Share by Country in 2025
Figure 56. Europe Amantadine HCl Oral Revenue Market Share by Country (2020-2025)
Figure 57. Europe Amantadine HCl Oral Sales Market Share by Type (2020-2025)
Figure 58. Europe Amantadine HCl Oral Sales Market Share by Application (2020-2025)
Figure 59. Germany Amantadine HCl Oral Revenue Growth 2020-2025 ($ millions)
Figure 60. France Amantadine HCl Oral Revenue Growth 2020-2025 ($ millions)
Figure 61. UK Amantadine HCl Oral Revenue Growth 2020-2025 ($ millions)
Figure 62. Italy Amantadine HCl Oral Revenue Growth 2020-2025 ($ millions)
Figure 63. Russia Amantadine HCl Oral Revenue Growth 2020-2025 ($ millions)
Figure 64. Middle East & Africa Amantadine HCl Oral Sales Market Share by Country (2020-2025)
Figure 65. Middle East & Africa Amantadine HCl Oral Sales Market Share by Type (2020-2025)
Figure 66. Middle East & Africa Amantadine HCl Oral Sales Market Share by Application (2020-2025)
Figure 67. Egypt Amantadine HCl Oral Revenue Growth 2020-2025 ($ millions)
Figure 68. South Africa Amantadine HCl Oral Revenue Growth 2020-2025 ($ millions)
Figure 69. Israel Amantadine HCl Oral Revenue Growth 2020-2025 ($ millions)
Figure 70. Turkey Amantadine HCl Oral Revenue Growth 2020-2025 ($ millions)
Figure 71. GCC Countries Amantadine HCl Oral Revenue Growth 2020-2025 ($ millions)
Figure 72. Manufacturing Cost Structure Analysis of Amantadine HCl Oral in 2025
Figure 73. Manufacturing Process Analysis of Amantadine HCl Oral
Figure 74. Industry Chain Structure of Amantadine HCl Oral
Figure 75. Channels of Distribution
Figure 76. Global Amantadine HCl Oral Sales Market Forecast by Region (2026-2031)
Figure 77. Global Amantadine HCl Oral Revenue Market Share Forecast by Region (2026-2031)
Figure 78. Global Amantadine HCl Oral Sales Market Share Forecast by Type (2026-2031)
Figure 79. Global Amantadine HCl Oral Revenue Market Share Forecast by Type (2026-2031)
Figure 80. Global Amantadine HCl Oral Sales Market Share Forecast by Application (2026-2031)
Figure 81. Global Amantadine HCl Oral Revenue Market Share Forecast by Application (2026-2031)